On March 27, 2024, Jacqueline Wright notified Exelixis, Inc. of her decision not to stand for re-election to the Board of Directors of the Company when her term expires at the Company?s 2024 annual meeting of stockholders. Ms. Wright will continue to serve as a director until the 2024 Annual Meeting and indicated that her decision not to stand for re-election was not the result of any disagreement with the Company on any matter relating to the Company?s operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.02 USD | -0.19% | +0.14% | -12.38% |
May. 20 | Exelixis Settles Cabometyx Patent Litigation with Cipla | MT |
May. 14 | Transcript : Exelixis, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 02:35 PM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.38% | 6.13B | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Jacqueline Wright Notifies Exelixis, Inc. of Her Decision Not to Stand for Re-Election to the Board of Directors